WNK2 and brain neoplasm: LGGs are the most common type of brain tumor in children, accounting for approximately 40%-50% of all pediatric brain tumors [4]. Although histology has long been used to classify LGGs, molecular diagnostics, specifically the identification of the up-regulation of the RAS-mitogen-activated protein kinase pathway, have led to targeted molecular therapies for LGGs [1].